Sorafenate
(Sorafenib)
(200 mg)
(112)
(Tablets)
Sorafenate (sorafenib) 200 mg 112 tab. CIPLA India
Article:
In Stock
Interchangeable drugs with the same active ingredient:
- Neskavar
- Sorafenate
- Sorafenib
- Sarafenib
Indications
- Renal cell carcinoma (RCC).
- Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma.
- Hepatocellular carcinoma (HCC).
- Nexavar is indicated for the treatment of patients with inoperable hepatocellular carcinoma.
- Differentiated thyroid cancer (DTC).
- Nexavar is indicated for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid cancer refractory to radioactive iodine treatment.
-
Commercial name:Sorafenate
-
Сhemical name:Sorafenib
-
Dosage:200 mg
-
Quantity:112
-
Release form:Tablets
No reviews yet